Titan Pharmaceuticals, Inc.
| OTC Markets: TTNP
Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of products for the treatment of central nervous system disorders, cardiovascular disease and cancer. The company's products include Fanapt, Proneura and Probuphine. It is currently focused on three late-stage development programs for treatments of schizophrenia, opiate addiction and Parkinson's disease. Titan Pharmaceuticals was founded by Louis R. Bucalo in 1992 and is headquartered in South San Francisco, CA.